{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:40:12Z","timestamp":1761183612520,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Lagos Central Research Committee","award":["01-000-63-6347"],"award-info":[{"award-number":["01-000-63-6347"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jphs.2020.07.013","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:55:05Z","timestamp":1596628505000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of nevirapine, efavirenz and lopinavir\/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria"],"prefix":"10.1016","volume":"144","author":[{"given":"Sikiru Olatunji","family":"Usman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Adekunle","family":"Oreagba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinwumi Akinyinka","family":"Akinyede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther Oluwatoyin","family":"Agbaje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshood Olusola","family":"Akinleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adaobi Goodness","family":"Onwujuobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chioma","family":"Ken-Owotor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olatunbosun","family":"Adeuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tosin","family":"Ogunfowokan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Segun","family":"Kogbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Tope","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Adeniji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Wasiu","family":"Busari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olayinka Olayiwola","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganiu","family":"Abideen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alani Sulaimon","family":"Akanmu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jphs.2020.07.013_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.sjbs.2016.03.006","article-title":"HIV epidemiology in Nigeria","volume":"25","author":"Awoyemi","year":"2018","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.jphs.2020.07.013_bib3","doi-asserted-by":"crossref","first-page":"b2141","DOI":"10.1136\/bmj.b2141","article-title":"Interaction of malaria and HIV in Africa","volume":"338","author":"Reithinger","year":"2009","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.jphs.2020.07.013_bib4","first-page":"103","article-title":"Antiretrovirals and co-prescribed drugs for people living with HIV\/AIDS (PLWHA) in a University Teaching Hospital, South west Nigeria","volume":"26","author":"Akanmu","year":"2015","journal-title":"West Afr. J Prm (Lahore)"},{"author":"Department of Health and Human Services","key":"10.1016\/j.jphs.2020.07.013_bib5"},{"issue":"4","key":"10.1016\/j.jphs.2020.07.013_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jphs.2018.11.016","article-title":"Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapy","volume":"139","author":"Luoa","year":"2019","journal-title":"J\u00a0Pharmacol Sci"},{"year":"2005","series-title":"Federal Republic of Nigeria: National Antimalarial Treatment Policy","key":"10.1016\/j.jphs.2020.07.013_bib7"},{"key":"10.1016\/j.jphs.2020.07.013_bib8","article-title":"The cross-sectional evaluation of the use of artemisinin-based combination therapy for treatment of malaria at a tertiary hospital in Nigeria","volume":"2018","author":"Okoro","year":"2018","journal-title":"J\u00a0Trop Med"},{"key":"10.1016\/j.jphs.2020.07.013_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1475-2875-9-275","article-title":"Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine","volume":"9","author":"Ali","year":"2010","journal-title":"Mal J"},{"issue":"3","key":"10.1016\/j.jphs.2020.07.013_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","article-title":"Pharmacokinetics and pharmacodynamics of lumefantrine (Benflumetol) in acute falciparum malaria","volume":"44","author":"Ezzet","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jphs.2020.07.013_bib11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/503423","article-title":"Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria","volume":"42","author":"Price","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jphs.2020.07.013_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"Artemether-lumefantrine treatment of uncomplicated malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jphs.2020.07.013_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12936-016-1327-1","article-title":"Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women","volume":"15","author":"Mutagonda","year":"2016","journal-title":"Mal J"},{"key":"10.1016\/j.jphs.2020.07.013_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jphs.2020.07.013_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2020.07.013_bib16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/0091270004269142","article-title":"Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital","volume":"44","author":"Hariparsad","year":"2004","journal-title":"J\u00a0Clin Pharmcol"},{"key":"10.1016\/j.jphs.2020.07.013_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.qai.0000219774.20174.64","article-title":"Lopinavir\/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers","volume":"42","author":"Yeh","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jphs.2020.07.013_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1254\/jphs.08209FP","article-title":"Induction of multiple drug transporters by efavirenz","volume":"109","author":"Wiessi","year":"2009","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2020.07.013_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1475-2875-8-289","article-title":"Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base","volume":"8","author":"Bouchaud","year":"2009","journal-title":"Mal J"},{"key":"10.1016\/j.jphs.2020.07.013_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/QAI.0b013e3181acb4ff","article-title":"Lopinavir\/ritonavir affects pharmacokinetic exposure of artemether\/lumefantrine in HIV-uninfected healthy volunteers","volume":"51","author":"German","year":"2009","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jphs.2020.07.013_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/QAI.0b013e31826ebb5c","article-title":"Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers","volume":"61","author":"Huang","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.jphs.2020.07.013_bib22","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1128\/AAC.05265-11","article-title":"Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients","volume":"55","author":"Kredo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jphs.2020.07.013_bib23","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jac\/dks207","article-title":"Significant pharmacokinetics interactions between artemether\/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults","volume":"67","author":"Byakika-Kibwika","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jphs.2020.07.013_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12936-015-0695-2","article-title":"The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment","volume":"14","author":"Maganda","year":"2015","journal-title":"Mal J"},{"issue":"1","key":"10.1016\/j.jphs.2020.07.013_bib25","first-page":"143","article-title":"The 2008 declaration of Helsinki- first among equals in research ethics?","volume":"38","author":"Annette","year":"2010","journal-title":"J\u00a0Law Med Ethics"},{"year":"2013","series-title":"Coartem (artemether\/lumefantrine) tablets prescribing information. East Hanover, NJ","key":"10.1016\/j.jphs.2020.07.013_bib26"},{"key":"10.1016\/j.jphs.2020.07.013_bib27","first-page":"CD005564","article-title":"Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria","author":"Omari","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jphs.2020.07.013_bib28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.1999.60.936","article-title":"Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria","volume":"60","author":"Vugt","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jphs.2020.07.013_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","article-title":"The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease","volume":"53","author":"Fridericia","year":"1920","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jphs.2020.07.013_bib30","first-page":"299","article-title":"Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection","volume":"681","author":"Zeng","year":"1996","journal-title":"J\u00a0Chromatogr"},{"year":"1997","series-title":"Guideline on validation of analytical procedures: methodology","author":"Food and Drug Administration","key":"10.1016\/j.jphs.2020.07.013_bib31"},{"issue":"6","key":"10.1016\/j.jphs.2020.07.013_bib32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4269\/ajtmh.1999.61.964","article-title":"No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine","volume":"61","author":"van Vugt","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jphs.2020.07.013_bib33","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa1200501","article-title":"Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children","volume":"367","author":"Achan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jphs.2020.07.013_bib34","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and Monitoring of hepatic injury II: recommendations for use in laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.jphs.2020.07.013_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00002030-200201250-00020","article-title":"Liver toxicity caused by nevirapine","volume":"16","author":"Gonzalez","year":"2002","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jphs.2020.07.013_bib36","first-page":"343","article-title":"Hepatotoxicity in patients prescribed efavirenz or nevirapine","volume":"13","author":"Bruck","year":"2008","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jphs.2020.07.013_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1472-8206.2007.00471.x","article-title":"Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects","volume":"21","author":"Asimus","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.jphs.2020.07.013_bib38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0090-9556(24)14960-4","article-title":"Characterization of the in\u00a0vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450","volume":"27","author":"Erickson","year":"1999","journal-title":"Drug Metab Dispo"},{"key":"10.1016\/j.jphs.2020.07.013_bib39","first-page":"30","article-title":"Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications of antiretroviral therapy in HIV-1 infected patients","volume":"16","author":"Hoglund","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jphs.2020.07.013_bib40","first-page":"636","article-title":"The interaction between artemether-lumefantrine and lopinavir\/ritonavir-based antiretroviral regimen","volume":"79","author":"Kredo","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.jphs.2020.07.013_bib41","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1128\/AAC.01153-15","article-title":"Artemether-lumefantrine exposure in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy","volume":"59","author":"Parikh","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:59:34Z","timestamp":1761163174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861320300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1347861320300785"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2020.07.013","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nevirapine, efavirenz and lopinavir\/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2020.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}